Gavin Kilpatrick, PhD

Gavin Kilpatrick Ph.D. is a pharmacologist with over 30 years of experience in the biotechnology and pharmaceutical sectors. He has held senior management positions at GSK, CeNeS, Paion, Roche, and Takeda. Moreover, he was a founder of the biotechnology company TheraSci Ltd. Gavin is a Fellow of the British Pharmacological Society, has authored or co-authored more than 80 academic publications, and contributed to the discovery and development of three drugs that have reached the market, most recently, remimazolam.